To clear up any misunderstanding about the FDA Singulair investig...

To clear up any misunderstanding about the FDA Singulair investigation. FROM THE FDA STATEMENT ABOUT THE SINGULAIR INVESTIGATION "FDA has not yet reached a definitive conclusion regarding the clinical trial data on mood and behavioral adverse events associated with montelukast, zafirlukast, and zileuton." "although (the clinical trial) data do not suggest that montelukast, zafirlukast, or zileuton are associated with suicide or suicidal behavior, these clinical trials were not designed specifically to examine neuropsychiatric events. As a result, some events may not have been reported." The FDA is continuing to investigate a link between Singulair and suicide . They stated that they have not "closed the book on suicidality". Any news reports stating there is no conclusive link are incorrect.